Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
Status:
Completed
Trial end date:
2019-07-06
Target enrollment:
Participant gender:
Summary
The Open-Label Maintenance Study contains an Correction Phase, in which subjects will be
dosed with ZS 10 g three times daily (tid) for 24 to 72 hours, followed by a 12-month
long-term Maintenance Phase.